TTAB Oppositions 91169425
USPTO Oppositions proceeding 91169425, filed 2006-02-17. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91169425 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2006-02-17 |
| Last Activity | 2006-07-18 |
| Days Active | 7393 |
Parties
- Breckenridge Pharmaceutical, Inc. — Defendant
- Aventis Pharma Deutschland GMBH — Plaintiff
Plaintiff Marks
- TRENTAL — Aventis Pharma Deutschland GMBH
Defendant Marks
- TRITAL DM — Breckenridge Pharmaceutical, Inc.
Recent Documents
- 2006-07-18: TERMINATED — Status
- 2006-07-18: BD'S DECISION: DISMISSED W/O PREJUDICE — Decisions
- 2006-07-12: WITHDRAWAL OF OPPOSITION — Withdrawals
- 2006-06-13: AMDT APPROVED; PL'S RESPONSE DUE 7-13-06 — Miscellaneous
- 2006-06-09: MOTION TO AMEND APPLICATION — Motions
- 2006-05-11: EXTENSION OF TIME GRANTED — Extensions
- 2006-05-11: STIPULATION FOR AN EXTENSION OF TIME — Extensions
- 2006-04-10: SUSPENDED — Status
- 2006-04-10: STIP TO SUSPEND PEND SETTLEMENT NEGOTNS — Motions
- 2006-02-27: PENDING, INSTITUTED — Status
- 2006-02-27: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2006-02-17: FILED AND FEE — Fees